Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Super Spectrim is a privately held U.S. nutritional supplements company focused on time-release multivitamin and mineral products. The company appears to have been founded in 1982 in Thousand Oaks, California, and is associated with founders Carol Venus and Carlin Venus. Its core business is the manufacture and sale of multivitamins, minerals, and related wellness products rather than prescription biopharmaceutical therapeutics. Available public information suggests it operates as a small consumer health and nutraceutical business with commercial products on the market. It does not appear to have a traditional drug-development pipeline, clinical-stage biotech assets, or disclosed therapeutic targets typical of biotech or pharma companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Super Spectrim.